Establishing new key performance indicators (KPI) for dialysis and transplantation - and refining existing measures - are among the recommendations from a review of our renal KPI program.
Since 2012 the Renal Clinical Network has monitored the performance of renal services across Victoria to drive service improvement and support better outcomes for patients with chronic kidney disease.
Safer Care Victoria produces quarterly KPI reports that compare how the state’s renal services are performing against these measures.
We recently reviewed all indicators and developed a number of recommendations to drive improvement.
What we found
We consulted with heads of Victorian renal units, members of our Renal Clinical Network and other key stakeholders on the current performance of the KPI program.
Our review found that several changes should be made to ensure the current measures are driving quality and safety improvement.
Our recommendations are to:
- develop a better measure of the quality of CKD education to replace KPI 1 and remove KPI 1a
- enhance the collection of data for KPI 2 on reasons why planned haemodialysis patients start dialysis without arteriovenous access.
- change KPI 3 to a benchmarking approach
- establish new KPIs to measure bloodstream infection rates in haemodialysis patients, standardised mortality ratio for dialysis patients and transplant patients, and risk-adjusted graft failure ratio for transplant patients.
- combine KPI 5 and 6 to capture renal transplant status at six and 12 months after beginning renal replacement therapy.
Throughout the next 12 months we will work with health services to implement these changes.
July 2019 – December 2019 will see the removal of KPI 1a, changes to KPI 3, 5 and 6 and the introduction of three new KPIs.
December 2019 – June 2020 will include
- replacing KPI 1 with a better measure of the quality of chronic kidney disease education
- introducing measures for vascular access bloodstream infection rates in haemodialysis patients
- collecting data on the reasons why planned haemodialysis (HD) patients commence HD without arteriovenous access.
(03) 9096 2676